Goldman Sachs refreshes conviction lists on both sides of the Atlantic
Goldman Sachs updated its U.S. and European conviction lists for September. In the U.S., Vertex Pharmaceuticals was added, while Interactive Brokers was removed. In Europe, RWE, Adyen, and Talanx were added, with Enel, Wise, Hannover Re, and Zalando removed. Analysts highlighted growth prospects and raised price targets for some companies.
How this was made
The 30-second read
Why it matters
The additions signal analyst confidence and could influence short‑term buying pressure, though no new earnings or deal information is disclosed.
Market read
List changes are a modest catalyst for the included stocks, primarily affecting sentiment-driven traders.
What to watch
List updates lack concrete earnings or deal data; price impact may be muted.
Background
Goldman Sachs periodically updates its conviction lists, highlighting stocks it expects to outperform.
Ticker impact
Vertex Pharmaceuticals added to Goldman Sachs US conviction list, indicating strong buy recommendation.
Expect upward pressure as investors follow conviction list.
Goldman Sachs upgrade signals strong growth prospects.
Estée Lauder added to Goldman Sachs US conviction list, suggesting bullish outlook.
Modest upside expected.
Analyst conviction lists often influence short-term demand.
Wells Fargo added to Goldman Sachs US conviction list, indicating positive view.
Slight upward bias.
Conviction inclusion signals confidence in earnings outlook.
UnitedHealth added to Goldman Sachs US conviction list, reflecting strong confidence.
Upward movement likely.
Analyst endorsement often moves large-cap health stocks.
Delta Air Lines added to Goldman Sachs US conviction list, implying bullish stance.
Potential modest gain.
Conviction list inclusion is a favorable signal.
ConocoPhillips added to Goldman Sachs US conviction list, indicating optimism.
Upward bias expected.
Analyst confidence can influence commodity‑linked equities.
Microsoft added to Goldman Sachs US conviction list, reinforcing bullish view.
Likely supportive of price gains.
Large‑cap tech inclusion signals strong fundamentals.
Talanx added to Goldman Sachs Europe conviction list, pointing to underappreciated growth drivers.
Modest upside anticipated.
Inclusion signals belief in future earnings expansion.
Market effects
Broadly positive for biotech, consumer, financials, energy and fintech sectors as Goldman Sachs signals confidence.
May lift US and European equity sentiment in the listed sectors.
Limited to investors tracking analyst conviction lists.
Counterpoint
Some investors may view conviction list changes as short‑term hype without fundamental catalyst.
Key entities
- Financial InstitutionGoldman Sachs
Provider of the conviction list updates.
